Dr Elin Haf Davies has combined her career in paediatric health and clinical and academic drug trials. She began her career as a Paediatric Nurse at Great Ormond Street Children’s Hospital in London, moving after 12 years to research in the development of age-appropriate and disease-specific biomarkers and clinical endpoints in neurometabolics.
Her current positions include: a CEO at Aparito, UK, the Chair at Metabolic Support, UK Research Fellow at the Centre for Health Economics & Medicines Evaluation at Bangor University, UK, and Associate Fellow Centre for the Advancement of Sustainable Medical Innovation (CASMI), UK.
Elin has been nominated in Tech50 women winners within Tech50 shortlist (2017).